The Effect of a Histone Deacetylase Inhibitor (AR‐42) on Canine Prostate Cancer Growth and Metastasis. Issue 7 (9th February 2017)

• Record Type: Journal Article
• Authors: Elshafae, Said M.; Kohart, Nicole A.; Altstadt, Lucas A.; Dirksen, Wessel P.; Rosol, Thomas. J.
• Is Part Of: Prostate. Volume 77:Issue 7(2017)
• Page Start: 776
• Page End: 793
• Publication Date: 2017-02-09
• Subjects: prostate cancer -- AR‐42 -- anoikis -- metastasis -- canine -- dog; Prostate -- Diseases -- Periodicals; 616
• DOI: 10.1002/pros.23318
• Languages: English
• ISSNs: 0270-4137

Abstract

Abstract : BACKGROUND: Canine prostate cancer (PCa) is an excellent preclinical model for human PCa. AR‐42 is a histone deacetylase inhibitor (HDACi) developed at The Ohio State University that inhibits the proliferation of several cancers, including multiple myeloma, lung, and hepatocellular cancer. In this study, we investigated whether AR‐42 would prevent or decrease. The growth and metastasis of a canine PCa (Ace‐1 cells) to bone in vitro and in vivo. METHODS: Proliferation, cell viability, invasion, and metastasis of a canine prostate cancer cell line (Ace‐1) were measured following treatment with AR‐42. Expression of anoikis resistance, epithelial‐to‐mesenchymal transition (EMT), and stem cell‐related markers were also evaluated. To assess the efficacy of AR‐42 on prevention of PCa metastasis to bone, Ace‐1 cells were injected in the left cardiac ventricle of nude mice, mice were treated with AR‐42, and the incidence and growth of bone metastasis were measured. Bioluminescence was performed to monitor the bone metastases in nude mice. RESULTS: AR‐42 inhibited the in vitro proliferation of Ace‐1 cells in a time‐ and dose‐dependent manner. The IC50 concentration of AR‐42 for Ace‐1 cells was 0.42 μM after 24 hr of treatment. AR‐42 induced apoptosis, decreased cell migration, and increased the stem cell properties of Ace‐1 cells in vitro. AR‐42 downregulated E‐cadherin, N‐cadherin, TWIST, MYOF, anoikis resistance, and osteomimicry genes, while it upregulated SNAIL, PTEN, FAK, and ZEB1 gene expression in Ace‐1 cells. Importantly, AR‐42 decreased the bioluminescence and incidence of bone metastasis in nude mice. In addition, AR‐42 induced apoptosis and altered the tumor cell morphology to an irregular cell phenotype with condensed chromatin in the bone metastases. CONCLUSION: AR‐42 decreased PCa growth and bone metastasis, induced apoptosis, and downregulated osteomimicry genes in PCa cells in the bone microenvironment. Prostate 77:776–793, 2017 . © 2017 Wiley Periodicals, Inc.